Kinnate Biopharma
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Kinnate Biopharma's balance sheet done over the years? Its assets were worth $173,605,000 last year, which is less than in the previous period. 8% of Kinnate Biopharma’s total assets is currently financed by debt. Its liabilities reached the amount of $14,278,000, which means an decrease by -30% compared compared to last year.

Debt to Assets

Kinnate Biopharma Inc. (NASDAQ:KNTE): Debt to assets
2018 8077000 467K 5.78%
2019 77605000 95.09M 122.53%
2020 400571000 7.30M 1.82%
2021 366864000 12.38M 3.38%
2022 278826000 20.35M 7.3%
2023 173605000 14.27M 8.22%

KNTE Balance Sheet (2018 – 2023)

2023 2022 2021 2020 2019 2018
Assets
Current assets:
Cash and cash equivalents
56.99M29.26M116.09M365.46M76.45M6.99M
Short term investments
97.03M172.21M103.36M31.39M00
Net receivables
0000973K1.07M
Inventory
000000
Other current assets
4.14M3.63M5.63M3.34M25K0
Total current assets
158.17M230.83M258.69M400.20M77.45M8.07M
Non-current assets:
Property, Plant and Equipment
4.76M6.44M956K368K154K0
Goodwill
000000
Intangible assets
000000
Long term investments
10.63M39.13M105.44M000
Other non-current assets
37.99K2.40M1.76M000
Total non-current assets
15.42M47.98M108.17M368K154K0
Total assets
173.60M278.82M366.86M400.57M77.60M8.07M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
000000
Short term debt
892K991K0000
Total current liabilities
11.99M17.16M12.38M7.30M1.94M467K
Non-current liabilities:
Long term debt
2.28M3.19M0000
Deferred tax
000000
Other non-current liabilities
0035M000
Total non-current liabilities
2.28M3.19M35M093.14M0
Total liabilities
14.27M20.35M12.38M7.30M95.09M467K
Data sourceData sourceData source